-
GSK links with Medicago to develop novel COVID-19 vaccine
pharmatimes
July 09, 2020
GSK and Canadian biopharma Medicago are joining forces on the development and evaluation of a COVID-19 candidate vaccine combining the former's recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic adjuvant system.
-
CureVac recieves €75 million loan for vaccine development and manufacturing expansion
europeanpharmaceuticalreview
July 09, 2020
The European Investment Bank (EIB) will provide three €25 million instalments to support CureVac’s vaccine development and expansion to mRNA production facilities.
-
CEPI expands Covid-19 vaccine alliance with Clover Biopharmaceuticals
pharmaceutical-technology
July 09, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) has expanded its collaboration with China-based Sichuan Clover Biopharmaceuticals to speed-up the development and manufacture of Covid-19 vaccine candidate.
-
Serum Institute of India expects COVID vaccine by year-end
expresspharma
July 09, 2020
He was speaking during the launch of 'Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, that will automate lab processes from sample handling to preparing RT-PCR tubes.
-
China’s Sinovac starts late stage trials for its COVID-19 vaccine
expresspharma
July 09, 2020
China’s Sinovac Biotech is starting Phase III trials of its potential coronavirus vaccine in Brazil, it said on Monday, becoming one of three companies to move into the late stages in the race to develop an inoculation against the disease.
-
Premas Biotech initiates triple antigen VLP COVID-19 vaccine candidate for animal trials
expresspharma
July 09, 2020
At the moment, it is the only one from India to adopt a triple-antigen approach that is designed to produce an enhanced immune response.
-
Novavax receives $1.6bn from US Government for Covid-19 vaccine
pharmaceutical-technology
July 08, 2020
Novavax has received $1.6bn under the US Government’s Operation Warp Speed (OWS) programme to support the development and manufacturing of its Covid-19 vaccine candidate.
-
GSK partners with Medicago to develop plant-based Covid-19 vaccine
pharmaceutical-technology
July 08, 2020
GlaxoSmithKline (GSK) has partnered with Canadian biopharmaceutical firm Medicago to develop, assess and manufacture a plant-based adjuvanted Covid-19 vaccine candidate.
-
‘At war time speed’, China leads COVID-19 vaccine race
expresspharma
July 08, 2020
Sinovac Biotech’s experimental vaccine set to become the country’s second and the world’s third to enter final stage testing later this month.
-
CureVac nets EU funding to ramp up vaccine production
expresspharma
July 07, 2020
CureVac, backed by the Bill & Melinda Gates Foundation, is a pioneer in the so-called messenger RNA approach, which is also being pursued by BioNTech and its partner Pfizer as well as Moderna.